AAAAAA
Results:
1-7
|
Results: 7
Authors:
Sundstrom, I
Bondesson, U
Hedeland, M
Citation: I. Sundstrom et al., Identification of phase I and phase II metabolites of ketobemidone in patient urine using liquid chromatography-electrospray tandem mass spectrometry, J CHROMAT B, 763(1-2), 2001, pp. 121-131
Authors:
Wang, MD
Backstrom, T
Sundstrom, I
Wahlstrom, G
Olsson, T
Zhu, D
Johansson, IM
Bjorn, I
Bixo, M
Citation: Md. Wang et al., Neuroactive steroids and central nervous system disorders, INT R NEURO, 46, 2001, pp. 421-459
Authors:
Backstrom, T
Appelblad, P
Bixo, M
Haage, D
Johansson, S
Landgren, S
Seippel, L
Sundstrom, I
Wang, MD
Wahlstrom, G
Citation: T. Backstrom et al., Female sex steroids, the brain and behaviour, MOOD DISORDERS IN WOMEN, 2000, pp. 189-205
Authors:
Sundstrom, I
Backstrom, T
Citation: I. Sundstrom et T. Backstrom, Endocrine response to pregnanolone, GYNECOL END, 13(5), 1999, pp. 352-360
Authors:
Sundstrom, I
Backstrom, T
Wang, M
Olsson, T
Seippel, L
Bixo, M
Citation: I. Sundstrom et al., Premenstrual syndrome, neuroactive steroids and the brain, GYNECOL END, 13(3), 1999, pp. 206-220
Authors:
Sundstrom, I
Spigset, O
Andersson, A
Appelblad, P
Backstrom, T
Citation: I. Sundstrom et al., Lack of influence of menstrual cycle and premenstrual syndrome diagnosis on pregnanolone pharmacokinetics, EUR J CL PH, 55(2), 1999, pp. 125-130
Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen
Authors:
Sundstrom, I
Nyberg, S
Bixo, M
Hammarback, S
Backstrom, T
Citation: I. Sundstrom et al., Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen, ACT OBST SC, 78(10), 1999, pp. 891-899
Risultati:
1-7
|